Amarin Corp Plc (AMRN)

[alm2]

Settlement - we need ask ourselves why would Hikma settle ? What is their risk? Their downside if they settle
- sets a precedent ( not necessarily a legal one ) that all pharma companies would follow against generics to protect their labels from skinny abuse - the life blood of generic business

If they don’t settle - triple damages ?? How much exactly .... they will have to way potential profit from generic sales against the damages they would have to pay .... how much would that be ????

If they think the financial risk is huge and can somehow duck the skinny label issue they may settle

When would they settle ???? Now ???

Not likely ... they know they can settle at the doors of the trial court- so 2023???
And what will they do between now and trial date ?? Assuming they have supply - will they flood the market with gv....or will they reign it in so they are not skinny label infringing as demonstrated by percentage of sales

What we have now is a new game/ phase in litigation that gives Amarin much more muscle - get the awaited gsk ruling on side and we have more muscle

And let’s not forget .... Marjac and team Rule 24/60

That would not be muscle in a battle for market but generic slaughter - a victory for truth and justice righting the appalling Du decision which has been so appallingly ignored by the American justice system

The Rule 24/60 case - needs a Federal Court panel who are judges that are prepared to deliver justice

Marjac may yet deliver the killer blow to the generic rip off merchants that we all so long to see
Alm